IN the course of a series of tests of iroii-containing compounds and irolicomplexes for carcinogenicity, it was found that a preparation of rat-ferritin induced not only a high incidence of sarcomata at the site of repeated subcutaneous injection, but also testicular atrophy, Leydig-cell hyperplasia and benign Leydigcell tumours (Haddow, Dukes and Mitchley, 1961 In this paper the induction of sarcomata at the site of subcutaneous injectiol-i of " rat-ferritin " or cadmium sulphate in rats is described and the failure to induce similar tumours in mice bv injection of the same agents, reported. In an accompanying paper (Roe et al., 1964 ) the testicular and pituitary changes following the injection of eadmi-Lun sulphate, or ferritin. are described and discussed.
effects of rat ferritin could be induced by iiijections of a cadmium salt alone. Cadmium sulphate was the salt chosen for this purpose.
Recently, and at about the time the experiments to be described were being completed, two reports of the carcinogenicity of cadmium appeared. Heath et al. (1962) injected 20 hooded rats intramuscularly with cadmium powder suspended in fowl serum, 10 of the rats receiving 28 mg. each and 10 receiving 14 mg. each. Altogether 15 of the 20 rats developed malignant tumours: rhabdomyosarcomata and fibrosarcomata. Kazantzis (19.63) injected 10 Wistar rats (Chester Beatty strain) subcutaneously at two sites with 25 mg. cadmium sulphide suspended in physiological saline. Sarcomata developed in 6 of the animals within 12 months. Neither of these authors described testic-Lilar changes in their experimental animals.
In this paper the induction of sarcomata at the site of subcutaneous injectiol-i of " rat-ferritin " or cadmium sulphate in rats is described and the failure to induce similar tumours in mice bv injection of the same agents, reported. In an accompanying paper (Roe et al., 1964 ) the testicular and pituitary changes following the injection of eadmi-Lun sulphate, or ferritin. are described and discussed.
MATERIALS AND ',,%IETHODS
Rats : Male albino rats of the Chester Beatty straiii were used. In the first experiment courses of injection were begun when the rats were 3-4 weeks old (80-1 00 g.), and in the third experiment when they were 6-7 weeks old (I 70-200 g.) .
(Rats of this strain are exceptionally large.) The rats were housed in metal cages in groups of 10, fed cubed Diet 86 on 2 days of each week and white bread plus milk, cod liver oil, margarine, or marmite on the 5 other davs. Water was provided ad libitum, Mice: Random-bred Chester Beatty stock strain mice were used in Experiments II and IV. All mice were vaccinated on the tail with sheep lymph as a precaution against ectromelia. Injections were begun when the mice were 6 weeks old (25-35 g.) . (Mice of this strain are exceptionally large.) Mice were housed in metal cages, 5 to a cage, fed Diet 41B and given water ad libitum.
Preparation of ferritin. The details of the preparation of ferritin are as follows :-Two kilograms of rat's liver were collected and homogenised with water and heated to 80°C. to coagulate. The mass was then filtered through muslin and subsequently through a Whatman No. 1 filter paper. A clear brown solution was obtained.
To each 100 ml. of the above solution ammonium sulphate (A.R. grade) (30 g.) was added and the suspension allowed to stand at 4°C. in a refrigerator overnight. The resulting precipitate was collected by centrifugation. It was then dissolved in water and filtered, cadmium sulphate solution (4-5 g. per 100 ml.) added, and the whole kept at 4°C. in a refrigerator for 2 days. The resulting precipitate was collected by centrifugation and dried in a desiccator. The dried crude ferritin was re-crystallised by dissolving in ammonium sulphate solution (10 %) to which was added cadmium sulphate solution (4 %o). After standing some time in the cold the ferritin was collected and rapidly washed with a saturated solution of potassium chloride.
The crystallisation of ferritin can be achieved by means of Zn, Cd, Ni or Co salts. Cadmium sulphate is the salt most commonly chosen for this. It seems necessary to have one of these elements present to form crystals. The cadmium may be considered to serve two functions; the first, to co-ordinate the molecules of ferritin into a definite lattice pattern; the second to decrease the solubility of ferritin, thus favouring crystallisation. The cadmium content of the re-crystallised ferritin was reduced by washing with a saturated potassium chloride solution, but some cadmium certainly remained in the final ferritin product used.
Chemicals. Crystalline cadmium sulphate with the formula Cd SO4. 4H20 was used, after a check had been made on its content of cadmium and water of crystallisation.
Observation of animals. Animals were examined regularly each week for the presence of tumours at the site of injection. They were killed when they became sick or developed rapidly growing injection-site tumours.
Post-mortem examination. All animals, whether killed because sick, or found dead, were subjected to careful post mortem examination. Organs showing pathological appearances were taken for histological examination.
Experiment I: Induction of Sarcomata at the Site of Subcutaneous Injection of Cadmium-precipitated Rat-Ferritin (in Rats) Twenty male rats, 3 weeks old, were injected subcutaneously in the right flank with ferritin prepared as above: the initial dose was 20 mg. but this caused severe ulceration at the injection site. A second dose of 20 mg. was given after an interval of 46 days and since this also caused a severe local reaction it was followed by eight doses of 2 mg. at weekly intervals, all given subcutaneously at the same site.
After 15 (Fig. 3 and 4) . Apart from tumour formation extensive calcification was sometimes seen at the injection site. Fig. 5 No injection-site tumours were observed in the cadmium-treated group but testicular atrophy, often with Leydig-cell hyperplasia, was present in almost all these animals (Roe et al., 1964) .
Generalised malignant lymphoma was observed in 4 of the cadmium-treated mice (in animals dvine after 8, 13, 16 and 19 months, respectively), and a locahsed reticulosarcoma was seen in an animal killed during the 15th month. In the untreated controls generalised malignant lymphoma was seen in 3 animals (9, 17, and 19 months, respectively, from the beginning of the observation period, i.e. when the mice were 7 weeks old). In addition, a mouse dying during the 8th month had a parenchymal-ceR tumour of the liver, one dying during the 9th month had a disseminated undifferentiated intra-abdominal adenocarcinoma of uncertain origin, and one dying during the 13th month had two small adenomatons tumours of the lung.
DISCUSSION
A yield of 7 injection-site sarcomata in 20 rats injected with rat-ferritin after an average latent interval of months is indicative of quite definite carcinogenicity of the injected material. On the other hand, the negative result obtained in 10 mice injected with a rather higher dose of rat-ferritin (on a body weight basis) is less meaningful, particularly because of their poor survival. After these experiments with rat-ferritin were complete it remained uncertain whether the injectionsite tumours, and the testicular changes and neoplasms (Roe et al., 1964) were due, as seemed likely, entirely to cadmium present in the ferritin or whether other constituents of the ferritin contributed to the effects seen. This problem persists since we have been unable so far to obtain a sample of ferritin which is free from cadmium. On the other hand, we have obtained further information on the carcinogenicity of cadmium in the absence of ferritin.
A total dose of 2-0 mg. Cd as CdSO4.4H20 gave rise to 14 injection-site sarcomata in 20 rats. This incidence of tumours was double that obtained with approximately half the dose of cadmium (0-95 mg.) given as rat-ferritin and the average induction time was very much shorter: only 13.3 months as compared with 21-6 months. From this comparison it would seem that as far as the induction of local tumours is concerned, the other constituents of ferritin had little effect on carcinogenicity of cadmium.
In ni-ice a total dose of cadmium (as cadmium sulphate) approximately equivalent, on a body weight basis, to that given to the rats (0-22 mg. as against 2-0 mg. for the rat) induced neither injection-site tumours nor testicular tumours (Roe et al., 1964) . The survival of the mice in this experiment was more satis- 
